Colorectal Cancer Clinical Trials in Texas

Showing 161-180 of 200 trials

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

NCT00381862

RATIONALE: Aprepitant, palonosetron, and dexamethasone may help lessen or prevent nausea and vomiting in patients receiving chemotherapy. PURPOSE: This phase II trial is studying how well giving aprepitant together with palonosetron and dexamethasone works in preventing nausea and vomiting caused by chemotherapy in patients receiving chemotherapy for metastatic colorectal cancer.

Colorectal CancerNausea and Vomiting

OHSU Knight Cancer Institute54 participantsStarted Jun 2006

Savannah, Georgia, United States • Hilo, Hawaii, United States • Harvey, Illinois, United States +3 more locations

COMPLETEDPhase 213 miles

Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer

NCT00023751

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining surgery with chemotherapy and radiation therapy may kill more tumor cells and prevent recurrence of the cancer. PURPOSE: Phase II trial to study the effectiveness of surgery with or without chemotherapy and radiation therapy in treating patients who have stage I rectal cancer.

Colorectal Cancer

Alliance for Clinical Trials in Oncology320 participantsStarted Jul 2001

Anniston, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +177 more locations

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer

Colorectal Cancer Trials in Other Cities

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Study of Ruxolitinib in Colorectal Cancer Patients

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer

Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy

Vitamin D/Calcium Polyp Prevention Study

A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Screening Tests in Detecting Colorectal Cancer

Gene Testing in Patients With Colon Cancer

Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer

Other Conditions in Texas